Yeo, Tianrong
Bayuangga, Halwan
Augusto-Oliveira, Marcus
Sealey, Megan
Claridge, Timothy D. W.
Tanner, Rachel
Leppert, David
Palace, Jacqueline
Kuhle, Jens
Probert, Fay
Anthony, Daniel C.
Funding for this research was provided by:
National Medical Research Council (NMRC/Fellowship/0038/2016)
Medical Research Council (MC_PC_15029)
Multiple Sclerosis Society (grant 59)
Article History
Received: 27 February 2022
Accepted: 26 September 2022
First Online: 9 October 2022
Declarations
:
: All animal procedures were performed with ethical approval under UK HO Licence P996B4A4E and in compliance with the ARRIVE guidelines.
: Not applicable.
: TY has received travel grants from UCB, Merck and PACTRIMS, and travel awards from ACTRIMS, ECTRIMS and Orebro University. His institution has received honoraria from ASNA, Terumo BCT, Edanz Pharma, Euroimmun AG, Merck, Novartis for consulting services and speaker fees, and research grants from the National Medical Research Council (NMRC Singapore) and Roche. FP has received travel awards from ECTRIMS, Merck, and the Multiple Sclerosis Society UK. JP is partly funded by highly specialized services to run a national congenital myasthenia service and a neuromyelitis service. She has received support for scientific meetings and honorariums for advisory work from Merck Serono, Biogen Idec, Novartis, Teva, Chugai Pharma and Bayer Schering, Alexion, Roche, Genzyme, MedImmune, EuroImmun, MedDay, Abide ARGENX, UCB and Viela Bio and grants from Merck Serono, Novartis, Biogen Idec, Teva, Abide, MedImmune, Bayer Schering, Genzyme, Chugai and Alexion. She has received grants from the MS society, Guthrie Jackson Foundation, NIHR, Oxford Health Services Research Committee, EDEN, MRC, GMSI, John Fell and Myaware for research studies. JK received speaker fees, research support, travel support, and/or served on advisory boards by ECTRIMS, Swiss MS Society, Swiss National Research Foundation, (320030_160221), University of Basel, Bayer, Biogen, Celgene, Merck, Novartis, Roche, Sanofi. HB, MAO, MS, TDWC, RT, DL, and DCA report no competing interests relevant to the manuscript.